国内老熟妇对白XXXXHD,护士奶头又白又大又好摸视频 ,亚洲欧美一区二区成人片,成人污污污WWW网站免费直播

您好,歡迎進(jìn)入上海力敏實(shí)業(yè)有限公司網(wǎng)站!
一鍵分享網(wǎng)站到:
您現(xiàn)在的位置:首頁(yè) >> 產(chǎn)品中心 >> 生化試劑、抗體、血清 >> 抗體/蛋白 >> santacruz SC-81805Talin-1 Antibody (YQ-16)

Talin-1 Antibody (YQ-16)

  • 更新時(shí)間:  2023-07-25
  • 產(chǎn)品型號(hào):  santacruz SC-81805
  • 簡(jiǎn)單描述
  • mouse monoclonal IgG3 provided at 100 µg/ml
    recommended for detection of Talin-1 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA
詳細(xì)介紹

SANTA CRUZ BIOTECHNOLOGY, INC.
Talin-1 (YQ-16): sc-81805
Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 831.457.3801 Europe +00800 4573 8000 49 6221 4503 0 www.scbt.com
BACKGROUND
Focal adhesions were identified as areas within the plasma membrane of
tissue culture cells that adhere tightly to the underlying substrate. In vivo,
these regions are involved in the adhesion of cells to the extracellular matrix.
Paxillin and vinculin are cytoskeletal, focal adhesion proteins that are components
of a protein complex that links the Actin network to the plasma
membrane. Vinculin binding sites have been identified on other cytoskeletal
proteins, including Talin-1 and α-actinin. In addition, vinculin, Talin-1, Talin-2
and α-actinin each contain Actin binding sites. Expression of vinculin, Talin-1
and Talin-2 have been shown to be affected by the level of Actin expression.
α-actinin has been shown to link Actin to integrins in the plasma membrane
through interactions with the vinculin and Talin complex or by a direct interaction
with integrin. Talin-2 is similar to Talin-1 but shows distinct patterns of
expression and cannot compensate for the loss of Talin-1.
REFERENCES
1. Burridge, K., et al. 1988. Focal adhesions: transmembrane junctions
between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell
Biol. 4: 487-525.
2. Gilmore, A.P., et al. 1992. Further characterization of the Talin-binding site
in the cytoskeletal protein vinculin. J. Cell Sci. 103: 719-731.
3.Wood, C.K., et al. 1994. Characterisation of the paxillin-binding site and
the C-terminal focal adhesion targeting sequence in vinculin. J. Cell Sci.
107: 709-717.
4. Gluck, U., et al. 1994. Modulation of α-actinin levels affects cell motility
and confers tumorigenicity on 3T3 cells. J. Cell Sci. 107: 1773-1782.
5. Schevzov, G., et al. 1995. Impact of Actin gene expression on vinculin,
Talin, cell spreading, and motility. DNA Cell Biol. 14: 689-700.
6. Hemmings, L., et al. 1996. Talin contains three Actin-binding sites each of
which is adjacent to a vinculin-binding site. J. Cell Sci. 109: 2715-2726.
7. Gilmore, A.P., et al. 1996. Regulation of vinculin binding to Talin and Actin
by phosphatidyl-inositol-4-5-bisphosphate. Nature 381: 531-535.
CHROMOSOMAL LOCATION
Genetic locus: TLN1 (human) mapping to 9p13.3; Tln1 (mouse) mapping to
4 B1.
SOURCE
Talin-1 (YQ-16) is a mouse monoclonal antibody raised against recombinant
Talin-1 of human origin.
PRODUCT
Each vial contains 100 μg IgG3 in 1.0 ml PBS with < 0.1% sodium azide and
0.1% gelatin.
STORAGE
Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of
shipment. Non-hazardous. No MSDS required.
APPLICATIONS
Talin-1 (YQ-16) is recommended for detection of Talin-1 of mouse, rat and
human origin by Western Blotting (starting dilution 1:200, dilution range
1:100-1:1000), immunoprecipitation [1-2 μg per 100-500 μg of total protein
(1 ml of cell lysate)], immunofluorescence (starting dilution 1:50, dilution
range 1:50-1:500), immunohistochemistry (including paraffin-embedded
sections) (starting dilution 1:50, dilution range 1:50-1:500) and solid phase
ELISA (starting dilution 1:30, dilution range 1:30-1:3000).
Suitable for use as control antibody for Talin-1 siRNA (h): sc-36610, Talin-1
siRNA (m): sc-36611, Talin-1 shRNA Plasmid (h): sc-36610-SH, Talin-1 shRNA
Plasmid (m): sc-36611-SH, Talin-1 shRNA (h) Lentiviral Particles: sc-36610-V
and Talin-1 shRNA (m) Lentiviral Particles: sc-36611-V.
Molecular Weight of Talin-1: 230 kDa.
Positive Controls: RAW 264.7 whole cell lysate: sc-2211.
RECOMMENDED SECONDARY REAGENTS
To ensure optimal results, the following support (secondary) reagents are
recommended: 1) Western Blotting: use goat anti-mouse IgG-HRP: sc-2005
(dilution range: 1:2000-1:32,000) or Cruz Marker™ compatible goat antimouse
IgG-HRP: sc-2031 (dilution range: 1:2000-1:5000), Cruz Marker™
Molecular Weight Standards: sc-2035, TBS Blotto A Blocking Reagent:
sc-2333 and Western Blotting Luminol Reagent: sc-2048. 2) Immunoprecipitation:
use Protein A/G PLUS-Agarose: sc-2003 (0.5 ml agarose/2.0 ml).
3) Immunofluorescence: use goat anti-mouse IgG-FITC: sc-2010 (dilution
range: 1:100-1:400) or goat anti-mouse IgG-TR: sc-2781 (dilution range:
1:100-1:400) with UltraCruz™ Mounting Medium: sc-24941. 4) Immunohistochemistry:
use ImmunoCruz™: sc-2050 or ABC: sc-2017 mouse IgG
Staining Systems.
DATA
SELECT PRODUCT CITATIONS
1. Ah Kioon, M.D., et al. 2010. Adrenomedullin increases fibroblast-like synoviocyte
adhesion to extracellular matrix proteins by upregulating integrin
activation. Arthritis Res. Ther. 12: R190.
RESEARCH USE
For research use only, not for use in diagnostic procedures.

 

上海力敏實(shí)業(yè)有限公司代理santacruz產(chǎn)品,咨詢 
上海力敏實(shí)業(yè)有限公司代理santazruz產(chǎn)品,咨詢 


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
成免费CRM在线看| A片在线观看| 久久精品人妻无码一区二区三区| 从镜子里看我怎么C你视频试| 丰满人妻一区二区三区视频53| 久久免费看少妇高潮片A特黄| 无码播放一区二区三区| 亚洲 自拍 另类 欧美 综合| 俄国一姐RAPPER潮水| 欧美丰满多毛少妇XXXXX性| 西欧FREE性满足HD| 法国少妇XXXX做受| 无码国内精品人妻少妇蜜桃视频| 欧美丰满老妇熟乱XXXXX视频 | 国模雨珍浓密毛大尺度150P| 最近高清中文字幕免费MV| 99久久精品无码一区二区毛片| 精品人妻无码一区二区三区, | 精品人妻VA出轨中文字幕| 精品国产AV无码一区二区三区| 小婕子的第一次好紧| 国产97在线 | 中文| 国产精品亚洲ΑV天堂无码| 疯狂的交换小雅小姿1~6| 他扒开我的裙底把舌头伸进去 | 麻豆国产精品色欲AV亚洲三区| 女人自己扒开荫道口视频| 我和同桌说我刚刚做了个梦| 亚洲夂夂婷婷色拍WW47| 黑人狂躁中国人的A片刘玥| 奶头又大又白喷奶水| 公咬着小娇乳H边走边欢视频 | 一夲道无码人妻精品一区二区| 小婷的性放荡日记H| 最近的2019免费中文字幕| 成人做爰A片免费看网站| 亚洲AV无码乱码国产精品麻豆 | 精品无码AV无码专区| 教室停电 挺进她体内H| 亚洲AV无码乱码日韩欧美| 亚洲AV无码乱码国产麻豆|